Chapter 2

Coronavirus Response, 116th United States Congress, May 12, 2020, “Testimony of Dr. Anthony Fauci,” (34:06 ).

“NIAID Budget Data Comparisons,” NIH/NIAID (2021). 

Dr. David E. Martin, “The Fauci/COVID-19 Dossier,” (Jan. 18, 2021). 

Teresa Carr, “Too Many Meds? America’s Love Affair with Prescription Medication,” Consumer Reports (Aug. 3, 2017). 

M. Jackson Wilkinson, “Lies, Damn Lies, and Prescriptions,” MJacksonw.com (Nov. 6, 2015). 

Maggie Fox, “United States Comes in Last Again on Health, Compared to Other Countries,” NBC News (Nov. 16, 2016). 

Peter C Gøtzsche, “Prescription drugs are the third leading cause of death,” The BMJ Opinion (Jun. 16, 2016). 

“Preventable Adverse Drug Reactions: A Focus on Drug Interactions,” U.S. Food and Drug Administration (Mar. 6, 2018). 

Bruce Nussbaum, Good Intentions: How Big Business and the Medical Establishment are Corrupting the Fight Against AIDS (Atlantic Monthly Press, 1990), 162.

Bruce Nussbaum, Good Intentions: How Big Business and the Medical Establishment are Corrupting the Fight Against AIDS (Atlantic Monthly Press, 1990), 162–163.

Daniel Payne, John Solomon, “Fauci Files: Celebrated doc’s career dotted with ethics, safety controversies inside NIH,” Just the News (Jul. 23, 2020). 

Marilyn L. Glynn, “Letter to Edgar M. Swindell” Just the News (Jul. 26, 2004). 

Marilyn L. Glynn, “Letter to Edgar M. Swindell” Just the News (Jul. 26, 2004). 

National Institutes of Health, Visiting Scientists, Outside Activity. 

“NIAID Budget Data Comparisons,” NIH/NIAID (2021).

Homeland Security News Wire, “U.S. Unprepared for Biological Attack,” Homeland Security News Wire, Dec. 1, 2011. *The National Institute of Allergy and Infectious Disease (NIAID) receives $1.6 billion annually for biodefense research via BARDA

J. Solomon, “Researchers mum on financial interests,” NBC News (Jan. 10, 2005). 

Information for NIH Inventors, Inventor Royalties, NIH Office of Technology Transfer. 

J. H. Tanne, “Royalty payments to staff researchers cause new NIH troubles,” BMJ (Jan. 22, 2005). 

“Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual Property,” US Government Accountability Office (Oct. 22, 2020). 

Dr. David E. Martin, “The Fauci/COVID-19 Dossier,” (Jan. 18, 2021). 

Dr. David E. Martin, “The Fauci/COVID-19 Dossier,” (Jan. 18, 2021). 

Dr. David E. Martin, “The Fauci/COVID-19 Dossier,” (Jan. 18, 2021). 

J. H. Tanne, “Royalty payments to staff researchers cause new NIH troubles,” BMJ (Jan. 22, 2005). 

Dr. David E. Martin, “The Fauci/COVID-19 Dossier,” (Jan. 18, 2021). 

“Proposed 1969 Budget Asks $1,196.6 Million Appropriation for NIH,” NIH Record (Feb. 6, 1968). 

Appropriations History by Institute/Center (1938 to Present), NIH Office of Budget. 

Ekaterina Galkina Cleary et al., “Contribution of NIH funding to new drug approvals 2010-2016,” PNAS (Mar. 6, 2018; first published Feb. 12, 2018). 

J. H. Tanne, “Royalty payments to staff researchers cause new NIH troubles,” BMJ (Jan. 22, 2005). 

Mark H. Furstenberg, “AZT the First AIDS Drug,” Washington Post (Sept. 15, 1987).